Trisalus Life Sciences earnings were -$57.8M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest TLSI earnings report on Mar 31, 2026 announced Q1 2026 earnings of $1.5M, down 115.8% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, TLSI reported annual earnings of -$69.7M, with 109.7% growth. The next TLSI earnings date is Aug 11, 2026.
Trisalus Life Sciences Earnings Reports & History FAQ
What were Trisalus Life Sciences's earnings last quarter?
Trisalus Life Sciences (NASDAQ: TLSI) reported Q1 2026 earnings per share (EPS) of $0.03, up 107.69% year over year. Total TLSI earnings for the quarter were $1.54 million. In the same quarter last year, Trisalus Life Sciences's earnings per share (EPS) was -$0.39.
The next TLSI earnings date is Invalid Date. Add TLSI to your watchlist to be reminded of Trisalus Life Sciences's next earnings date.
Is Trisalus Life Sciences profitable or losing money?
As of the last Trisalus Life Sciences earnings report, Trisalus Life Sciences is currently losing money. Trisalus Life Sciences's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$27.31 million, a 0.36% increase year over year.
What was TLSI's earnings growth in the past year?
As of Trisalus Life Sciences's earnings date in Q2 2026, Trisalus Life Sciences's earnings has grown year over year. TLSI earnings in the past year totalled -$57.78 million.
What are Trisalus Life Sciences's earnings expectations?
The current EPS estimate for Trisalus Life Sciences's earnings report in Invalid Date is -$0.11.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.